A fear of needles in a medical setting (often called trypanophobia when it’s more severe) is common and can make TRT ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis® intradermal (ID) Needle-free Injection System overcomes ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Xolair, an anti-immunoglobulin E antibody, is indicated for the treatment of moderate to severe persistent asthma, chronic idiopathic urticaria, and nasal polyps. The Food and Drug Administration (FDA ...
Previously, the treatment had only been supplied in a single-dose vial that required administration by a health care professional using a winged infusion set. The Food and Drug Administration (FDA) ...
You might be able to give yourself shots of your medicine at home as part of your treatment for rheumatoid arthritis. Self-injections may be an option for you if your RA doctor (rheumatologist) ...
– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback